Docetaxel is a newly developed taxoid anticancer agent.
多西他赛是新的紫杉类抗癌药物。
Data suggest that docetaxel (t) may add to the efficacy of PF.
数据表明多西他赛(T)可能增加PF方案的有效性。
Finally, I will conclude by discussing new trials with docetaxel.
最后，我将总结有关泰索帝治疗胃癌的临床研究。
OS benefit is obtained with early use of pemetrexed but not docetaxel;
早期应用培美曲赛对OS是获益的而不是多西他赛；
Objective HPLC method was established for injection of docetaxel content.
目的建立了HPLC法测定注射用多西他赛的含量。
Results Determines of docetaxel quantity 97.4% to sample of the indication.
结果测定多西他赛注射液样品中多西他赛含量为标示量的97.4%。
Docetaxel, when combined with cisplatin, results in very respectable response rate.
泰索帝与顺铂联合可产生较佳的缓解率。
In 2005, docetaxel was ranked 34, and three other oncologic blockbusters made the top 50 list.
在2005年，紫杉醇名列34位，而其它三个肿瘤要的拳头产品进入销量榜前50强。
These results indicate that interaction between docetaxel and cisplatin is highly schedule dependent.
多烯紫杉醇与顺铂的相互作用具有高度给药顺序依赖性。
In addition, the present invention also discloses the preparation process of the docetaxel crystal form.
此外，本发明还公开了该多烯紫杉醇晶型的制备方法。
Objective: to observe the effects and toxicity of docetaxel plus DDP in treatment of advanced breast cancer.
目的：观察国产多烯紫杉醇联合顺铂治疗晚期乳腺癌的疗效及毒副反应。
Recent years, there are many studys about docetaxel-base regimen in patients with advanced gastric in the world.
近年来国际上报道了大量含多西紫杉醇的方案治疗晚期胃癌的研究。
Such findings confirm the data from Fidias et al with respect to docetaxel, and the 4 studies had a similar design.
这种研究发现证实了来自Fidias等关于多西他赛的研究结果，而且4项大型的临床研究都有相似的试验设计。
Methods: Docetaxel liposomes were prepared by modified film dispersion-high pressure homogenization and lyophilization.
方法：采用改良薄膜分散法结合冷冻干燥工艺制备多西他赛脂质体冻干粉；
In the second study, the UK team studied 28 men whose cancer was growing despite treatment with the chemotherapy drug docetaxel.
在第二个研究中，英国研究小组对28名接受过多烯紫杉醇化疗而肿瘤仍继续增长的患者进行了研究。
It ranked 82 on the top 100 list of best selling drugs, along with docetaxel and oxaliplatin-the only other oncologic drugs on the list.
在药物销量百强榜中名列82，同时出现在名单上的肿瘤药物仅有紫杉醇和奥沙利。
Finally, they tested the approach in mice with an ovarian cancer cell line known to be resistant to taxane-based drugs such as docetaxel.
最后，他们检测了对紫衫烷为基础的药物如紫杉萜抵抗的卵巢癌细胞系的小鼠。
Background and Objective: Docetaxel combined with cisplatin is established as first-line therapy for advanced non-small cell lung cancer (NSCLC).
背景与目的：多西紫杉醇联合顺铂被确定为治疗晚期非小细胞肺癌的一线方案之一。
The European licence was recently extended in July 2009 to allow combination with another commonly used taxane based chemotherapy called docetaxel.
最近的2009年7月欧洲的联合用药许可证拓展到了另外一个常用的紫三烷类的化疗药多西他塞。
Objective To compare the efficacy and toxicity of docetaxel as a single agent for treating metastatic breast cancer with weekly and 3 weekly scheme.
目的研究单药多烯紫杉醇每周方案及每3周方案治疗转移性乳腺癌的疗效与毒性。
And, finally, significant improvement in several quality of life parameters were noted to both docetaxel groups as compared with the control regimen.
并且，泰索帝2组的生活质量参数与对照组相比有显著改善。
Objective To evaluate the efficacy and toxicity of docetaxel plus oxaliplatin in the treatment of platinum resistance advanced epithelia ovary cancer.
目的评价国产多西他赛联合奥沙利铂作为铂类耐药的晚期卵巢上皮癌解救化疗的疗效和毒性。
Objective To investigate the efficacy and safety of domestic docetaxel plus cisplatin regimen in patients with advanced non-small-cell lung cancer (NSCLC).
目的评价国产多西紫杉醇治疗晚期非小细胞肺癌的临床疗效和安全性。
Docetaxel combined with DDP has high efficiency and low toxicities in the treatment of advanced breast cancer. It is worthy of further clinical observation.
多烯紫杉醇联合顺铂治疗晚期乳腺癌有效率较高，毒副反应较小，值得临床进一步研究。
Objective to evaluate the recent efficacy and toxicity of docetaxel combined with cisplatin and 5-fu in the treatment of patients with metastatic esophageal cancer.
目的观察多西他赛联合顺铂和5 -氟脲嘧啶方案治疗转移性食管癌的近期疗效和毒副反应。
The median time to progression - the primary end point - was significantly longer (9.8 months) among those on the combination, compared to those on docetaxel alone (7.0 months).
中位进展时间—首要观察终点—与所有单用多西他赛方案(7.0月)相比联合方案组的中位进展时间(9.8月)明显延长。
Objective: To investigate the efficacy and safety of docetaxel administrated weekly plus carboplatin in the treatment of patients with advanced non-small-cell lung cancer (NSCLC).
目的：探讨多西他赛(艾素)每周给药联合卡铂治疗晚期非小细胞肺癌的临床疗效和不良反应。
Objective To evaluate the clinical efficacy of the regimen of docetaxel combined with oxaliplatin, 5-fluorouracil and calcium folinate in the treatment of advanced gastric cancer.
目的考察多西紫杉醇联合奥沙利铂、5 -氟尿嘧啶和亚叶酸钙方案治疗晚期胃癌的临床效果。
As the current evidence shows, pemetrexed has similar efficacy to docetaxel for advanced NSCLC patients, but it has fewer side effects of neutropenia, febrile neutropenia and alopecia.
结论当前证据显示，培美曲塞与多西紫杉醇治疗晚期NSCLC的疗效相当，但可减少中性粒细胞减少、粒细胞性发热和脱发等不良反应。
As the current evidence shows, pemetrexed has similar efficacy to docetaxel for advanced NSCLC patients, but it has fewer side effects of neutropenia, febrile neutropenia and alopecia.
结论当前证据显示，培美曲塞与多西紫杉醇治疗晚期NSCLC的疗效相当，但可减少中性粒细胞减少、粒细胞性发热和脱发等不良反应。
应用推荐